Arbutus Biopharma Corp (NASDAQ:ABUS)
| 2.04 BATS BZX Real-Time Price As of 9:45am ET |  -0.01 / -0.49%Today’s Change | 1.69 Today|||52-Week Range 3.15 | -12.45% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 2.05 |
| Today’s open | 2.05 |
| Day’s range | 2.01 - 2.06 |
| Volume | 1,418 |
| Average volume (3 months) | 653,531 |
| Market cap | $311.9M |
Data as of 9:45am ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +44.68% |
| Earnings growth (this year) | +2.61% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | +255.11% |
| P/E ratio | NM |
| Price/Sales | 9.01 |
| Price/Book | 2.14 |
Competitors
| ---- | ||
| HROWHarrow Inc | -0.08 | -0.87% |
| MRNSMarinus Pharmaceutic... | -0.12 | -1.78% |
| ORTXOrchard Therapeutics... | +0.02 | +0.12% |
Data as of 9:46am ET, 12/01/2023
Financials
| Next reporting date | February 29, 2024 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $39.0M |
| Annual profit (last year) | -$69.5M |
| Net profit margin | -178.01% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |
Forecasts
